The table below shows Zenas BioPharma, Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
Revenue
$10.00M
$5.00M
$50.00M
Cost of revenue
-
-
-
Gross profit
-
-
-
R&D
$168.06M
$139.14M
$60.03M
SG&A
$53.32M
$29.75M
$17.11M
Operating income
-$383.06M
-$163.89M
-$37.15M
Income tax
-$79.00K
$429.00K
$301.00K
Net income
ZBIO annual revenue (10-K history)
Zenas BioPharma, Inc. reported annual revenue of $10.00M for fiscal year 2025. That is up 100.0% from $5.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.